MACH7 TECHNOLOGIES LIMITED — Board/Management Information 2020

Dec 28, 2020

ASX Announcement

==> picture [104 x 26] intentionally omitted <==

Director Appointment

Melbourne, Australia; 29 December 2020 : Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX:M7T) is pleased to announce it has appointed Mr Philippe Houssiau as a Non-Executive Director, effective from 1 January 2021.

2020 has been a transformational year for Mach7 and the business continues to grow rapidly. To support this growth, the Board believes the timing is appropriate to add an additional NonExecutive Director to the Board with both CEO and Chair experience to complement the skills of the Board.

Philippe has held a variety of executive and board member roles for Healthcare IT companies across the globe. His experience as a small company owner, consultancy partner, entrepreneur, CEO and chairman will bring a depth of experience that will assist the Company in executing significant strategic, financial, and operational outcomes.

Previously, Philippe has held the role of CEO for Agfa Healthcare and Alliance Healthcare. He was a partner with Hg Private Equity and Chairman of Orion Health. Philippe has also held various senior manager roles with Price Waterhouse.

Mach7 welcomes Philippe’s passion for innovation and his willingness to drive operational and organisational growth at Mach7. Mach7 Chairman, David Chambers, said: “We are extremely pleased to welcome a person of Philippe’s standing in the global Healthcare IT community to the Mach7 Board. Philippe’s expertise, drawn from broad experience as a CEO and Chairman of Healthcare related companies, particularly within the global Diagnostic Imaging market, will prove to be invaluable.”

Philippe is based in Antwerp, Belgium.

This announcement has been approved for lodgment by the Board.

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) develops innovative data management solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Mach7’s award-winning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their bestof-breed clinical ecosystems. Mach7’s sophisticated workflow tools, advanced clinical viewing and optimized vendor neutral archiving solutions unlock silos of legacy systems empowering healthcare providers to own, access and share patient data without boundaries. Visit Mach7t.com.

For more information, contact:

Jenni Pilcher CFO, Mach7 jenni.pilcher@mach7t.com

Andrew Keys Investor Relations andrew.keys@keysthomas.com

Registered Office: Tower 4, 727 Collins Street Docklands, 3008

==> picture [74 x 9] intentionally omitted <==

Mach7 Technologies Limited ABN 26 007 817 192 ASX:M7T